Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20028633HPVENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TVIS20027872HPVENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TVIS20070100HPVENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TVIS20027871HPVENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TVIS20069680HPVENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TVIS44022884HTLV-1ENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TVIS44022885HTLV-1ENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TVIS44020006HTLV-1ENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TVIS44049194HTLV-1ENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TVIS44045896HTLV-1ENSG00000254087.8protein_codingLYNYesNo4067P07948
Q6NUK7
TCGA Plot Options
Drug Information
GeneLYN
DrugBank IDDB06616
Drug NameBosutinib
Target IDBE0004315
UniProt IDP07948
Regulation Typeinhibitor
PubMed IDs30969999; 23493838
CitationsBerndt S, Gurevich VV, Iverson TM: Crystal structure of the SH3 domain of human Lyn non-receptor tyrosine kinase. PLoS One. 2019 Apr 10;14(4):e0215140. doi: 10.1371/journal.pone.0215140. eCollection 2019.@@Amsberg GK, Koschmieder S: Profile of bosutinib and its clinical potential in the treatment of chronic myeloid leukemia. Onco Targets Ther. 2013;6:99-106. doi: 10.2147/OTT.S19901. Epub 2013 Mar 4.
GroupsApproved
Direct Classification4-aminoquinolines
SMILESCOC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl
PathwaysBosutinib Inhibition of BCR-ABL
PharmGKB
ChEMBLCHEMBL288441